- Home
- KROS vs URG Comparison
KROS vs URG Comparison
Compare KROS & URG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | URG |
|---|---|---|
| Founded | 2015 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.3M | 699.3M |
| IPO Year | 2020 | 2006 |
Fundamental Metrics
Financial Performance| Metric | KROS | URG |
|---|---|---|
| Price | $11.29 | $1.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $21.86 | $2.57 |
| AVG Volume (30 Days) | 321.2K | ★ 8.2M |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $243,864,000.00 | $27,207,000.00 |
| Revenue This Year | N/A | $200.42 |
| Revenue Next Year | $2,751.79 | $98.46 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.79 | $0.74 |
| 52 Week High | $22.55 | $2.35 |
Technical Indicators
Market Signals| Indicator | KROS | URG |
|---|---|---|
| Relative Strength Index (RSI) | 48.57 | 47.66 |
| Support Level | $10.47 | $1.42 |
| Resistance Level | $12.43 | $1.74 |
| Average True Range (ATR) | 0.68 | 0.12 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 59.09 | 32.41 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project; Shirley Basin; Other U.S. Projects.